Steven Ringold, DVM, DACVR, discusses his Fetch On-Demand lecture and what attendees can learn from it.

At Children’s Hospital of Philadelphia, an 11-year-old girl with severe beta thalassamia, became the first pediatric patient to receive Zyntelgo, the first FDA-approved gene therapy for ...